SMTL ID : 7fem.1

SARS-CoV-2 B.1.1.7 S-ACE2 complex

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-3-1-mer

Ligands

16 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.1: 2 residues within 4Å: Chain A: N.692, G.1114 No protein-ligand interaction detected (PLIP) NAG-NAG.2: 2 residues within 4Å: Chain A: N.700, Q.909 No protein-ligand interaction detected (PLIP) NAG-NAG.3: 4 residues within 4Å: Chain A: K.778, N.784, S.786, Q.787 No protein-ligand interaction detected (PLIP) NAG-NAG.4: 1 residues within 4Å: Chain A: N.1057 No protein-ligand interaction detected (PLIP) NAG-NAG.5: 3 residues within 4Å: Chain A: N.1081, H.1084, F.1086 No protein-ligand interaction detected (PLIP) NAG-NAG.6: 1 residues within 4Å: Chain A: N.1117 No protein-ligand interaction detected (PLIP) NAG-NAG.7: 1 residues within 4Å: Chain B: N.692 No protein-ligand interaction detected (PLIP) NAG-NAG.8: 2 residues within 4Å: Chain B: N.700, Q.1054 No protein-ligand interaction detected (PLIP) NAG-NAG.9: 3 residues within 4Å: Chain B: N.784, S.786, Q.787 No protein-ligand interaction detected (PLIP) NAG-NAG.10: 1 residues within 4Å: Chain B: N.1057 No protein-ligand interaction detected (PLIP) NAG-NAG.11: 1 residues within 4Å: Chain B: N.1117 No protein-ligand interaction detected (PLIP) NAG-NAG.12: 1 residues within 4Å: Chain C: N.692 No protein-ligand interaction detected (PLIP) NAG-NAG.13: 3 residues within 4Å: Chain C: N.700, L.905, Q.1054 1 PLIP interactions: 1 interactions with chain C Hydrophobic interactions: C:L.905 NAG-NAG.14: 2 residues within 4Å: Chain C: N.784, Q.787 No protein-ligand interaction detected (PLIP) NAG-NAG.15: 3 residues within 4Å: Chain C: A.689, E.1055, N.1057 1 PLIP interactions: 1 interactions with chain C Hydrophobic interactions: C:A.689 NAG-NAG.16: 4 residues within 4Å: Chain C: N.1081, T.1083, H.1084, F.1086 No protein-ligand interaction detected (PLIP)

27 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.17: 4 residues within 4Å: Chain A: Y.14, T.15, N.16, N.47 Ligand excluded by PLIP NAG.18: 3 residues within 4Å: Chain A: E.116, F.117, N.148 Ligand excluded by PLIP NAG.19: 3 residues within 4Å: Chain A: T.92, N.217, T.219 Ligand excluded by PLIP NAG.20: 3 residues within 4Å: Chain A: E.264, N.265 Chain C: K.541 Ligand excluded by PLIP NAG.21: 1 residues within 4Å: Chain A: N.586 Ligand excluded by PLIP NAG.22: 2 residues within 4Å: Chain A: N.599, T.601 Ligand excluded by PLIP NAG.23: 3 residues within 4Å: Chain A: H.638, V.639, N.640 Ligand excluded by PLIP NAG.24: 2 residues within 4Å: Chain B: Y.14, N.47 Ligand excluded by PLIP NAG.25: 3 residues within 4Å: Chain B: E.116, F.117, N.148 Ligand excluded by PLIP NAG.26: 3 residues within 4Å: Chain B: T.92, N.217, T.219 Ligand excluded by PLIP NAG.27: 1 residues within 4Å: Chain B: N.265 Ligand excluded by PLIP NAG.28: 4 residues within 4Å: Chain B: G.322, F.325, N.326, V.350 Ligand excluded by PLIP NAG.29: 2 residues within 4Å: Chain B: T.585, N.586 Ligand excluded by PLIP NAG.30: 1 residues within 4Å: Chain B: N.599 Ligand excluded by PLIP NAG.31: 2 residues within 4Å: Chain B: H.638, N.640 Ligand excluded by PLIP NAG.32: 2 residues within 4Å: Chain B: N.314, Q.563 Ligand excluded by PLIP NAG.33: 2 residues within 4Å: Chain B: N.106, T.108 Ligand excluded by PLIP NAG.34: 4 residues within 4Å: Chain B: N.1081, T.1083, H.1084, F.1086 Ligand excluded by PLIP NAG.35: 2 residues within 4Å: Chain C: Y.14, N.47 Ligand excluded by PLIP NAG.36: 2 residues within 4Å: Chain C: T.92, N.217 Ligand excluded by PLIP NAG.37: 2 residues within 4Å: Chain C: N.263, N.265 Ligand excluded by PLIP NAG.38: 2 residues within 4Å: Chain C: N.314, Q.563 Ligand excluded by PLIP NAG.39: 4 residues within 4Å: Chain C: F.321, G.322, F.325, N.326 Ligand excluded by PLIP NAG.40: 1 residues within 4Å: Chain C: N.586 Ligand excluded by PLIP NAG.41: 2 residues within 4Å: Chain C: N.599, T.601 Ligand excluded by PLIP NAG.42: 2 residues within 4Å: Chain C: N.640, N.641 Ligand excluded by PLIP NAG.43: 1 residues within 4Å: Chain C: N.1117 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Xia, S. et al., Structure-based evidence for the enhanced transmissibility of the dominant SARS-CoV-2 B.1.1.7 variant (Alpha). Cell Discov (2021)

Release Date

2021-12-15

Peptides

Spike glycoprotein: ABC
Angiotensin-converting enzyme 2: D

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

D
D

Spike glycoprotein

Angiotensin-converting enzyme 2

Related Entries With Identical Sequence